Total Company Value: Telomir Pharmaceuticals (TELO)

The market price action for Telomir Pharmaceuticals (TELO) visualized on GURU.Markets illustrates the dynamics of a brand focused on tissue regeneration and anti-aging. The enterprise value stands at 65.95, with production outsourced to third-party contractors to minimize technical risks. The market is showing significant hype surrounding innovative telomere lengthening methods, which strengthens the company's authority within the scientific community.

telomirpharma.com (TELO) Total Company Value: for the period 11/23/2025 - 10/30/2026

Telomir Pharmaceuticals (TELO) - metric breakdowns and financial figures

- market value and analyst target forecast:

Market Price Telomir Pharmaceuticals Inc|TELO - Price Target Chart

- company stock exchange capitalization indicators:

Market Value Telomir Pharmaceuticals|TELO - Total Company Value

- business book valuation details:

Net Asset Value per Share Telomir Pharmaceuticals|TELO - Company Book Value|Market Capitalization to Net Assets telomirpharma.com|TELO - Company Total Assets

- debt level and financial liquidity data:

- earnings and market multiples details:

TELO - Net Income

Analysis of all company metrics:Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals (TELO) is implementing green chemistry and bioethics principles into the development of anti-aging therapies. The enterprise value aggregates market capitalization and debt, subtracting cash to determine the total acquisition price of the business. For the investor, this metric reveals the actual value of assets accounting for all liabilities. This analysis allows for an assessment of the efficiency of capital investments in sustainable biotechnologies. The price action of the company's real market value reflects its fundamental stability.

Competitors of Telomir Pharmaceuticals (TELO)

Haleon PLC (HLN) - Total Enterprise Value|KVUE - Total Company Value|VRNA: Total Company Value|Jyong Biotech Ltd (MENS) - Total Company Value|Total Enterprise Value ligand.com (LGND)|Total Company Value Amneal|Perrigo Company PLC - Full Business Value|Enterprise Value ALVO|LQDA (Liquidia Inc.) - Value Adjusted for Debt and Cash|Enterprise Value GLPG (Galapagos NV)|Enterprise Value anipharmaceuticals.com ANIP|MNKD - Total Company Value|Value Adjusted for Debt and Cash AMPH (Amphastar Pharmaceuticals Inc)|Pacira (PCRX) - Total Company Value|Real Price to Acquire Entire Company ARS Corp|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com|Real Price to Acquire Entire Company SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Value Adjusted for Debt and Cash|Total Company Value Tonix Pharmaceuticals Inc. TNXP|SXT Pharmaceuticals (SXTC) - Total Enterprise Value|EPRX: Real Price to Acquire Entire Company|bioharvest.com - Aggregate Business Value|EXOZ: Enterprise Value|Oramed Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|ENTX (Entera Bio Ltd) - Enterprise Value|Total Enterprise Value MindWalk Therapeutics HYFT|Total Company Value ABVC BioPharma (ABVC)|CPIX (cumberlandpharma.com) - Value Adjusted for Debt and Cash|Quantum BioPharma - Real Price to Acquire Entire Company|Aggregate Business Value FGEN (FibroGen Inc)|Rani Therapeutics Inc - Enterprise Value|Total Enterprise Value Synergy CHC Corp|rallybio.com (RLYB) - Total Company Value|LEXX (Lexaria Bioscience Corp.) - Total Company Value|Total Company Value Pulmatrix|Total Enterprise Value Pheton PTHL|Total Company Value Aptorum Group Limited (APM)|Real Price to Acquire Entire Company Lyra Therapeutics Inc LYRA|Enterprise Value IBO (Impact BioMedical)|Company Buyout Price TNF Pharmaceuticals Inc. (TNFA)|YCBD - Total Company Value|Value Adjusted for Debt and Cash PRFX (PainReform Ltd)|CYTO (altamiratherapeutics.com) - Real Price to Acquire Entire Company|Lipella Pharma - Value Adjusted for Debt and Cash|Total Company Value OptiNose, Inc.|pieris.com - Full Business Value|Enterprise Value PROC|PTPI (Petros Pharmaceuticals Inc) - Value Adjusted for Debt and Cash|Enterprise Value QLI (Qilian International Holding Group Limited)|Enterprise Value ACELYRIN Inc. SLRN|TFFP - Total Company Value